[SURBL-Discuss] Keep getting this spam, not listed in multi.
martin.lyberg at idkommunikation.com
Tue Nov 16 09:24:50 CET 2004
Joe Wein wrote:
> Stocks spams don't advertise websites of spams but stocks the spammer owns.
> pinksheets.com is a domain created in 1996. It's in the SURBL whitelist. It
> not only has > 400 NANAS sightings but also 50 misc.invest.stocks sightings,
> i.e. legitimate uses.
Ok, can you (or someone else) please give me an advice how to stop this
spam? I'm using different SARE rules and others, but it won't catch this
spam. Since my first post i've recieved about five more of this spam.
Thanks in advance.
-------------- next part --------------
Received: from aspam at _mydomain_.com (192.168.2.80 [192.168.2.80]) by exchangeserver.id.local with SMTP (Microsoft Exchange Internet Mail Service Version 5.5.2653.13)
id VAQVTM0S; Mon, 15 Nov 2004 11:19:39 +0100
Received: by aspam at _mydomain_.com (Postfix, from userid 500)
id 47A2713889; Mon, 15 Nov 2004 11:19:41 +0100 (CET)
Received: from 218-162-208-81.dynamic.hinet.net (218-162-208-81.dynamic.hinet.net [18.104.22.168])
by aspam at _mydomain_.com (Postfix) with SMTP
id 3C46713886; Mon, 15 Nov 2004 11:19:32 +0100 (CET)
Subject: Personal Investment Advise
Message-ID: <TYBJpb8R3.oSPjiDCpYQ6 at tegucigalpa9.fourfa.com>
From: "Meredith Hudson" <watermellon at emosaustin.com>
To: "Meredith Hudson" <watermellon at emosaustin.com>
Cc: bengt.lundahl at _mydomain_,
christian.kapusta at _mydomain_, info at _mydomain_,
johnny.nilsson at _mydomain_
Date: Mon, 15 Nov 2004 06:10:24 -0400
X-Spam-Checker-Version: SpamAssassin 2.63 (2004-01-11) on
aspam at _mydomain_.com
X-Spam-Status: No, hits=4.9 required=5.0 tests=HTML_MESSAGE,
<html>Please review this entire email about:<br>
Pink Sheets Stock Symbol MTDN<br>
Big year expected in 2005 for Motion DNA<br>
Trading Symbol MTDN<br>
Current Price (est.) $0.025<br>
Valued Price (est.) $1.00<br><br>
First time investors please read this:<br>
Company officials expect to make the move to become a reporting company, due to their high expectations Motion DNA may surpass revenue projections for 2005. Currently with almost $500,000 in assets, zero debt, and increasing interest in its franchise program, company officials term the financial viability of Motion DNA as "solid". "All of the road blocks appear to be removed and Motion DNA expects to increase its market presence in the sports medicine industry and improve company revenues substantially," said Zig Ziegler, President of Motion DNA. "We can now focus on increasing customer awareness and sales of our products and services."
In a move expected to provide future franchisees with access to a solid customer base, Motion DNA officials have agreed to terms with one of the nation's leading health club chains with over 430 locations in the US and Europe. Motion DNA is expected to launch its first analysis center in one of the club?s Arizona locations. Franchisees will be awarded locations as part of their territories. A formal announcement is expected within the coming weeks.
Motion DNA is scheduled to demonstrate its newest pitching and overhead analysis at the upcoming Minor League Baseball Tradeshow. The tradeshow, scheduled for December 10, 11, and 12, coincides with the annual Winter Meetings for Major League Baseball. Representatives from more than 200 Major League and Minor League Baseball clubs, leagues and organizations typically attend the Baseball Trade Show during their annual meetings. In addition, baseball representatives, coaches, and organizers from Independent League, College, High School and Little League, as well as other baseball affiliated organizations are invited to attend the Baseball Trade Show. Current Major League Player Ramon Hernandez of the San Diego Padres and an endorser of Motion DNA is expected to attend the event and assist in promoting the company to his big league peers. Canadian Olympian Fastpitch Softball Player Lauren Bay, is also expected to attend the tradeshow along with other company officials
More about Motion DNA <br>
Motion DNA Corporation provides diagnostic testing for medical professionals and sports organizations. Motion DNA's biomechanical analyses and detailed reports provide its licensees and consumers with solutions for preventing injuries, identifying physical limitations, diagnosing pre-existing injuries related to biomechanics, and improving physical performance levels.
More information about the Discuss